PRESS RELEASE published on 11/15/2024 at 13:30, 1 year 9 months ago 2024 China Huangshan Book Fair Opens in Hefei, Marking Several 'Firsts' The 2024 China Huangshan Book Fair in Hefei, Anhui Province features thematic, international, digital, and lifestyle elements. Includes diverse cultural activities, offline and online sub-venues, publications, technology showcases, and a specialized marketplace Digitalization Internationalization Cultural Activities Specialized Marketplace China Huangshan Book Fair
PRESS RELEASE published on 11/15/2024 at 13:30, 1 year 9 months ago Justera Health Announces Management Change Justera Health Ltd. announces changes in leadership, with Mr. Young Cho Lee stepping down as CEO and Mr. Joshua Herman taking over. The company aims to continue its growth and success Leadership Changes CEO Company Growth Justera Health Ltd. Joshua Herman
PRESS RELEASE published on 11/15/2024 at 13:11, 1 year 9 months ago TitanSafe Utilizes Bank Branch Closures: Repurposing Former Bank Locations for Digital Safe Deposit Box Facilities | Bond WKN: A383EA TitanSafe repurposes former bank locations into secure digital safe deposit box facilities, offering nationwide access and 24/7 availability through innovative use of infrastructure Expansion Strategy TitanSafe Bank Branch Closures Secure Deposit Boxes Digital Facilities
PRESS RELEASE published on 11/15/2024 at 13:00, 1 year 9 months ago FAVO Capital Recognized with the 2024 Innovation & Excellence Award from Business Honor FAVO Capital, Inc. receives the Innovation & Excellence Award 2024 from Business Honor magazine for their commitment to redefining excellence in small business financing and disrupting the alternative financing market Alternative Financing FAVO Capital Innovation & Excellence Award Small Business Financing Business Honor Magazine
PRESS RELEASE published on 11/15/2024 at 13:00, 1 year 9 months ago Theralase(R) Closes Non-Brokered Private Placement Theralase® Technologies Inc. successfully closes non-brokered private placement offering of units for cancer research and development funding Private Placement Offering Drug Development Clinical Study Cancer Research Theralase® Technologies Inc.
PRESS RELEASE published on 11/15/2024 at 12:50, 1 year 9 months ago Final outcome in Eurobattery Minerals’ rights issue – receives approximately SEK 21.3 million Eurobattery Minerals AB concludes rights issue with 60.0% subscription rate, raising approx. SEK 21.3 million for feasibility study and debt repayment Rights Issue Subscription Rate Eurobattery Minerals Debt Repayment Feesibility Study
PRESS RELEASE published on 11/15/2024 at 12:50, 1 year 9 months ago Repurchase of Convertible Bonds Jet2 plc announces the repurchase of £50.0m of its 1.625% guaranteed convertible bonds due 2026, at a weighted average price of 103.78% Convertible Bonds Financial News Repurchase Announcement Jet2 Plc
PRESS RELEASE published on 11/15/2024 at 12:45, 1 year 9 months ago LFTD Partners Inc. Reports Third Quarter 2024 Financial Results LFTD Partners Inc. reports financial results for Q3 2024 with revenue decrease and net loss. Balance sheet shows decrease in cash and current assets. Earnings conference call scheduled Financial Results Earnings Conference Call Revenue Decrease Net Loss LFTD Partners Inc.
PRESS RELEASE published on 11/15/2024 at 12:30, 1 year 9 months ago MSC receives all regulatory approvals for participation in HHLA MSC receives all regulatory approvals for participation in HHLA. All closing conditions of the voluntary public takeover offer have been fulfilled, with shareholders receiving € 16.75 per HHLA class A share Shareholders Regulatory Approvals Public Takeover Offer HHLA MSC
PRESS RELEASE published on 11/15/2024 at 12:30, 1 year 9 months ago NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID NanoViricides, Inc. files Quarterly Report on Form 10-Q with the SEC, highlights financial results and progress on NV-387 antiviral drug for various infections including MPox and RSV NanoViricides NV-387 Quarterly Report SEC Filing Antiviral Drug
Published on 08/27/2026 at 02:00, 1 hour 12 minutes ago Algo Grande Copper Announces Upsizing of Private Placement
Published on 08/27/2026 at 00:05, 3 hours 7 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 4 hours 12 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 4 hours 42 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/27/2026 at 03:00, 12 minutes ago Hong Kong Fashion Fest presents eight flagship programmes for its third edition
Published on 08/26/2026 at 23:05, 4 hours 6 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 8 hours 27 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 8 hours 31 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 8 hours 42 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:02, 9 hours 10 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 9 hours 12 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 9 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 9 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026